Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
$4.2 million total revenue for the full year 2021 2021 highlights include Current Procedural Terminology (CPT) codes for prescribers, first...
Day: March 28, 2022
Andau Medical Inc. Signs Exclusive Canadian Distribution Agreement with Mercury Medical for Airtraq Effective March 17, 2022
Mercury Medical Has Selected Andau Medical As Their Canadian Airtraq Video Laryngoscope System Distribution Partner With the Signing of an...
Planet 13 Announces Q4 and Full Year 2021 Financial Results
Q4 2021 revenue of $29.9 million, up 48% compared to Q4 2020Q4 2021 net loss of $5.1 million, compared to...
TRxADE HEALTH Reports Year End 2021 Financial Results
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT PlatformTAMPA, FL / ACCESSWIRE / March 28, 2022 / TRxADE HEALTH,...
NeoGenomics Announces CEO Departure and Initiates CEO Search
Board Appoints Executive Chair and Interim Office of the CEOAnticipates First Quarter Results Below Guidance and Withdraws 2022 GuidanceFT. MYERS,...
Former Deputy OPP Commissioner Becomes NCACT Executive Director
Toronto, Ontario--(Newsfile Corp. - March 28, 2022) - The National Coalition Against Contraband Tobacco's (NCACT) announced today that former Deputy...
Outcome Capital Expands Its HealthTech and Digital Health Practice with the Addition of Karl Hess as Managing Director
BOSTON--(BUSINESS WIRE)--Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Karl Hess...
Cosmos Holdings Launches Proprietary Sky Premium Life Prostatium Supplement for Prostate Health
Designed to prevent and protect against Benign Prostate Hyperplasia, which affects millions of men worldwideCHICAGO, IL / ACCESSWIRE / March...
NLS Pharmaceutics Announces Early Access Program (EAP) Allowing Patients with Idiopathic Hypersomnia to Receive Treatment with Mazindol ER
Named Patient Program (NPP) enables physicians to prescribe the Company's novel Mazindol Extended-Release (ER) formulation to patients who have failed...
Empower Clinics Announces Closing of $2.1 Million Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / March...
Shineco, Inc. Announces Board and Officer Changes
BEIJING, March 28, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of...
Plantable Health Inc. Announces 2021 Financial Results
New York, New York--(Newsfile Corp. - March 28, 2022) - Plantable® Health Inc. (NEO: PLBL) ("Plantable" or the "Company"), a...
GE Healthcare Announces First Patient Dosed in Phase III Clinical Trial for New Dopamine Transporter Imaging Radiopharmaceutical
First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical...
Kareo and PatientPop Named Leaders by Real Users in G2 Spring 2022 Grid Report
Companies Recognized for Medical Billing, Patient Engagement, and Patient Scheduling IRVINE, Calif.--(BUSINESS WIRE)--#Kareo--Kareo, the leading provider of cloud-based clinical and...
Nanomerics Announces Quotient Sciences as its Clinical Trials Partner
LONDON, UK / ACCESSWIRE / March 28, 2022 / Nanomerics Ltd., a private speciality pharmaceutical company, today announced that the...
25 Dosell are Implemented in a New Municipality
STOCKHOLM, SWEDEN / ACCESSWIRE / March 28, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Hepro...
Relief Therapeutics Reports In Vivo Data Indicating Prolonged Release of Amino Acids Using its Physiomimic(TM) Technology May Have Benefits for the Treatment of PKU
Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports In Vivo Data Published in the Peer Reviewed, International Journal...
New Study Finds That Noninvasive and Continuous Hemoglobin Improved Transfusion Management and Outcomes in Pediatric Patients
Children Monitored with Masimo SpHb® Had Less Blood Transfusion, Less Bleeding, and Shorter ICU Stays NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI)...